The recommended dose is 25 mg twice weekly (50 mg/week), 3 or 4 days apart. Methotrexate (MTX), corticosteroids, salicylates, non-steroidal anti-inflammatory drugs (NSAIDs) or analgesics may be continued during treatment with Etarfion.
Administration: Etarfion powder for injection is reconstituted with 1 mL Water for Injection (WFI) before use, and administered by subcutaneous injection. Sites for injection (thighs, abdomen or upper arms) should be rotated. Never inject into areas where the skin is tender, bruised, red or hard.
Other Services
Country
Account